GH Research (GHRS) Accumulated Expenses (2020 - 2025)
GH Research (GHRS) recorded quarterly Accumulated Expenses of $1.6 million in Q4 2025, down 18.7% quarter-over-quarter from $2.0 million in Q3 2025, and down 13.26% on a YoY basis from $1.9 million in Q4 2024.
GH Research (GHRS) Accumulated Expenses (2020 - 2025) Analysis & Trends
GH Research's Accumulated Expenses history runs 6 years deep, the most recent figure standing at $1.6 million for Q4 2025.
- In Q4 2025, Accumulated Expenses fell 13.26% year-over-year to $1.6 million; the TTM figure through Dec 2025 stood at $1.6 million (down 13.26% YoY), while the FY2025 annual figure was $1.6 million, down 58.07% from the prior year.
- Accumulated Expenses was $1.6 million for Q4 2025 at GH Research, down from $2.0 million in the prior quarter.
- In the past five years, Accumulated Expenses ranged from a high of $2.4 million in Q4 2022 to a low of $1.4 million in Q2 2025.
- Historically, Accumulated Expenses has averaged $1.9 million across 5 years, with a median of $1.9 million in 2024.
- The sharpest annual moves came in 2021 and 2024: Accumulated Expenses soared 601.65% in 2021, then slipped 19.57% in 2024.
- A 5-year view of Accumulated Expenses shows it stood at $1.7 million in 2021, then soared by 39.34% to $2.4 million in 2022, then dropped by 1.73% to $2.3 million in 2023, then slipped by 19.57% to $1.9 million in 2024, then fell by 13.26% to $1.6 million in 2025.
- The last three Accumulated Expenses figures came in at $1.6 million (Q4 2025), $2.0 million (Q3 2025), and $1.4 million (Q2 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Alterity Therapeutics | 723,416.35 Bn | 723,416.32 Bn | - |
| 2 | Belite Bio | 57,340.00 Bn | 57,340.00 Bn | - |
| 3 | Quantum Biopharma | 19,125.08 Bn | 19,125.08 Bn | - |
| 4 | Legend Biotech | 3,262.00 Bn | 3,261.71 Bn | 242.10 Mn |
| 5 | Akari Therapeutics | 1,789.67 Bn | 1,789.67 Bn | - |
| 6 | Evaxion A | 1,480.39 Bn | 1,480.37 Bn | - |
| 7 | Psyence Biomedical | 241.78 Bn | 241.78 Bn | - |
| 8 | Vertex Pharmaceuticals | 113.54 Bn | 106.29 Bn | 2.59 Bn |
| 9 | Abivax | 94.26 Bn | 94.26 Bn | - |
| 10 | GH Research | 9.73 Bn | 9.63 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 1.62 Mn |
| Sep 30, 2025 | 2.00 Mn |
| Jun 30, 2025 | 1.38 Mn |
| Dec 31, 2024 | 1.87 Mn |
| Dec 31, 2023 | 2.33 Mn |
| Dec 31, 2022 | 2.37 Mn |
| Dec 31, 2021 | 1.70 Mn |
| Dec 31, 2020 | 242,000.00 |